A detailed history of Etesian Wealth Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Etesian Wealth Advisors, Inc. holds 6,790 shares of JNJ stock, worth $1.04 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
6,790
Previous 8,746 22.36%
Holding current value
$1.04 Million
Previous $1.28 Billion 13.92%
% of portfolio
0.5%
Previous 0.72%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $284,558 - $327,395
-1,956 Reduced 22.36%
6,790 $1.1 Billion
Q2 2024

Jul 25, 2024

SELL
$144.38 - $157.78 $301,032 - $328,971
-2,085 Reduced 19.25%
8,746 $1.28 Billion
Q1 2024

Apr 12, 2024

SELL
$155.22 - $162.74 $40,667 - $42,637
-262 Reduced 2.36%
10,831 $1.71 Billion
Q4 2023

Jan 16, 2024

BUY
$145.6 - $158.88 $10,628 - $11,598
73 Added 0.66%
11,093 $1.74 Billion
Q4 2023

Jan 12, 2024

BUY
$145.6 - $158.88 $10,628 - $11,598
73 Added 0.66%
11,093 $1.74 Billion
Q3 2023

Jan 16, 2024

SELL
$155.75 - $174.48 $6,697 - $7,502
-43 Reduced 0.39%
11,020 $1.72 Billion
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $6,697 - $7,502
-43 Reduced 0.39%
11,020 $1.72 Billion
Q2 2023

Jan 16, 2024

SELL
$154.35 - $166.11 $31,950 - $34,384
-207 Reduced 1.84%
11,063 $1.83 Billion
Q2 2023

Oct 19, 2023

SELL
$154.35 - $166.11 $31,950 - $34,384
-207 Reduced 1.84%
11,063 $1.83 Billion
Q1 2023

Jan 16, 2024

SELL
$151.05 - $180.26 $16,011 - $19,107
-106 Reduced 0.93%
11,270 $1.75 Billion
Q1 2023

Oct 19, 2023

SELL
$151.05 - $180.26 $16,011 - $19,107
-106 Reduced 0.93%
11,270 $1.75 Billion
Q4 2022

Jan 16, 2024

BUY
$160.2 - $179.79 $45,336 - $50,880
283 Added 2.55%
11,376 $2.01 Billion
Q4 2022

Oct 19, 2023

BUY
$160.2 - $179.79 $1.82 Million - $2.05 Million
11,376 New
11,376 $2.01 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Etesian Wealth Advisors, Inc. Portfolio

Follow Etesian Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Etesian Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Etesian Wealth Advisors, Inc. with notifications on news.